These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 18570244

  • 1. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y.
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872
    [Abstract] [Full Text] [Related]

  • 3. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
    Singh T, Katiyar SK.
    Int J Oncol; 2011 Mar 04; 38(3):769-76. PubMed ID: 21225228
    [Abstract] [Full Text] [Related]

  • 4. [Effects of honokiol on proliferation and apoptosis of human cervical carcinoma cell line Hela in vitro].
    Yang GL, Hou WL, Fu AF, Zhong ZH, Yin XH, Chen LJ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul 04; 39(4):558-62. PubMed ID: 18798493
    [Abstract] [Full Text] [Related]

  • 5. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
    Chen YJ, Wu CL, Liu JF, Fong YC, Hsu SF, Li TM, Su YC, Liu SH, Tang CH.
    Cancer Lett; 2010 May 01; 291(1):20-30. PubMed ID: 19880244
    [Abstract] [Full Text] [Related]

  • 6. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
    Stover TC, Sharma A, Robertson GP, Kester M.
    Clin Cancer Res; 2005 May 01; 11(9):3465-74. PubMed ID: 15867249
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D, Lu Q, Hu X.
    Cancer Lett; 2006 Nov 18; 243(2):274-80. PubMed ID: 16406853
    [Abstract] [Full Text] [Related]

  • 8. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y.
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep 18; 140(1):95-102. PubMed ID: 18440692
    [Abstract] [Full Text] [Related]

  • 9. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
    Wang X, Yuan S, Wang J, Lin P, Liu G, Lu Y, Zhang J, Wang W, Wei Y.
    Toxicol Appl Pharmacol; 2006 Sep 01; 215(2):168-78. PubMed ID: 16563451
    [Abstract] [Full Text] [Related]

  • 10. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC.
    J Gastroenterol Hepatol; 2008 Jul 01; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [Abstract] [Full Text] [Related]

  • 11. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER, Arlotti JA, Marynowski SW, Singh SV.
    Clin Cancer Res; 2008 Feb 15; 14(4):1248-57. PubMed ID: 18281560
    [Abstract] [Full Text] [Related]

  • 12. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR.
    Clin Cancer Res; 2010 May 01; 16(9):2571-9. PubMed ID: 20388852
    [Abstract] [Full Text] [Related]

  • 13. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells.
    Wang Y, Yang Z, Zhao X.
    Toxicol Mech Methods; 2010 Jun 01; 20(5):234-41. PubMed ID: 20374036
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.
    Liu Y, Chen L, He X, Fan L, Yang G, Chen X, Lin X, DU L, Li Z, Ye H, Mao Y, Zhao X, Wei Y.
    Int J Gynecol Cancer; 2008 Jun 01; 18(4):652-9. PubMed ID: 17892458
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro.
    Park EJ, Zhao YZ, Kim YH, Lee BH, Sohn DH.
    Planta Med; 2005 Jan 01; 71(1):82-4. PubMed ID: 15678380
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 01; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.